Tuberculosis - Nov 21, 2023 - Oral antibiotic taken once-daily for six months reduces risk of developing drug-resistant TB

Can't see this email? View it online

	Tuberculosis
	The latest tuberculosis news from News Medical

Oral antibiotic taken once-daily for six months reduces risk of developing drug-resistant TB

Two landmark clinical trials reported today at the Union meeting showed that an oral antibiotic taken for six months once-daily substantially reduced the risk of developing drug-resistant TB.

			New hope for TB patients as UNITE4TB launches clinical trial program Today, UNITE4TB, an international public-private partnership striving to fast-track the development of innovative Tuberculosis (TB) treatments, announced the start of its phase 2B/C clinical trial program with the first participant enrolled at its trial site in Cape Town, South Africa.

			Promising new cancer therapy appears to be extremely potent against tuberculosis A promising new cancer therapy also appears extremely potent against one of the world's most devastating infectious diseases: tuberculosis (TB).

	New study reveals turmeric and Tinospora Cordifolia reduce liver injury risk in TB patients The effectiveness of herbs and alternative medicines in preventing liver injury induced by anti-tuberculosis (anti-TB) drugs.

	Breakthrough in tuberculosis treatment: TB-PRACTECAL trial reveals efficacy of new oral regimen The TB-PRACTECAL clinical trial outcomes, which evaluated the efficacy and safety of oral bedaquiline.

Website: www.news-medical.net

Email: [email protected]

Telephone: +44 (0)161 457 7150

AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not interested anymore?
Unsubscribe or
Update Your Newsletter Subscriptions